mHealth Behavioural Intervention to Increase Breast Cancer Screening Rates Among Members of the Public
NCT ID: NCT06293508
Last Updated: 2024-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
1180 participants
INTERVENTIONAL
2024-04-30
2024-10-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Based on this promising prospect, a randomized controlled trial will be designed to study the effects of applying persuasive health communication materials to initiate behavior change among a group of Malaysian women. Materials are delivered in the form of a health communication program over a social messaging application to promote breast cancer screening practices, which is either a clinical breast examination, or a mammogram. The investigators hypothesize that Malaysian women who are exposed to such materials that are designed based on behavior science and behavior change principles will be nudged and hence more likely to attend breast cancer screening compared to a control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mobile Health (mHealth) Black Women With Breast Cancer
NCT02463474
Utility of a Mobile Application for Young Women With Breast Cancer
NCT07009093
Trial to Evaluate the Impact of Various Behavioural Interventions to Increase Mammography Uptake Among Singaporean Women
NCT07283107
Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations
NCT05264532
Interventions to Increase Screening by Breast Cancer Survivors and Their High Risk Female Relatives
NCT01612338
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants in the main experimental group will be compared with a control group, and another group which undergoes a standard health communication program.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Arm
Participants do not receive any message throughout the study period.
No interventions assigned to this group
Experimental Arm 1
Participants in this group will receive a message on a weekly basis throughout the intervention period, which is 6 months, via WhatsApp.
Standard Health Communication Intervention
Participants in this group will receive links and materials related to breast cancer screening from official sources (e.g. MOH, Non-governmental organizations (NGOs), etc.) that is already readily available and accessible by the Malaysian public. Frequency, duration, and platform of dissemination will be based on findings from Phase 1 of this study.
Experimental Arm 2
Participants in this group will receive a message on a weekly basis throughout the intervention period, which is 6 months, via WhatsApp.
Behavioural Change Health Communication Intervention
Participants receive health communication materials designed using persuasive behavioural change communication principles and behavior science to promote breast cancer screening. Frequency, duration, and platform of dissemination will be based on findings from Phase 1 of this study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard Health Communication Intervention
Participants in this group will receive links and materials related to breast cancer screening from official sources (e.g. MOH, Non-governmental organizations (NGOs), etc.) that is already readily available and accessible by the Malaysian public. Frequency, duration, and platform of dissemination will be based on findings from Phase 1 of this study.
Behavioural Change Health Communication Intervention
Participants receive health communication materials designed using persuasive behavioural change communication principles and behavior science to promote breast cancer screening. Frequency, duration, and platform of dissemination will be based on findings from Phase 1 of this study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Possess a smartphone with the predetermined social messaging application (derived from Phase 1 of study) installed.
3. Have not been diagnosed with cancer before.
Exclusion Criteria
2. Mammogram screening in the past 2 years.
3. Subjects who are deemed to have cognitive impairment and unable to provide consent to the study.
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, Malaysia
OTHER_GOV
National University of Malaysia
OTHER
Institute for Health Behavioral Research, Malaysia
UNKNOWN
Clinical Research Centre, Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicholas Hing Yee Liang
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicholas Yee Liang Hing, MSc
Role: PRINCIPAL_INVESTIGATOR
Institute for Clinical Research, National Institutes of Health, Malaysia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Clinical Research, National Institutes of Health, Malaysia
Shah Alam, Selangor, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NMRR ID-22-02616-I2I
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.